Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring-Reference-Cited by-同舟云学术

Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring

Published:2011-08 Issue:8 Volume:10 Page:745-758
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Kappos Ludwig,Bates David,Edan Gilles,Eraksoy Mefkûre,Garcia-Merino Antonio,Grigoriadis Nikolaos,Hartung Hans-Peter,Havrdová Eva,Hillert Jan,Hohlfeld Reinhard,Kremenchutzky Marcelo,Lyon-Caen Olivier,Miller Ariel,Pozzilli Carlo,Ravnborg Mads,Saida Takahiko,Sindic Christian,Vass Karl,Clifford David B,Hauser Stephen,Major Eugene O,O'Connor Paul W,Weiner Howard L,Clanet Michel,Gold Ralf,Hirsch Hans H,Radü Ernst-Wilhelm,Sørensen Per Soelberg,King John

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference91 articles.

1. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis;Polman;N Engl J Med,2006

2. MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS;Miller;Neurology,2007

3. Natalizumab significantly increases the cumulative probability of sustained improvement in physical disability;Munschauer;Mult Scler,2008

4. The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL;Hutchinson;J Neurol,2009

5. Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study;Havrdova;Lancet Neurol,2009

Cited by 243 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infiltration by monocytes of the central nervous system and its role in multiple sclerosis: reflections on therapeutic strategies;Neural Regeneration Research;2024-04-03

2. Inflammatory bowel disease is associated with an increase in the incidence of multiple sclerosis: a retrospective cohort study of 24,934 patients;European Journal of Medical Research;2024-03-20

3. Cladribine tablets after treatment with natalizumab (CLADRINA) – rationale and design;Therapeutic Advances in Neurological Disorders;2024-01

4. Virus Infections of the Nervous System;Manson's Tropical Diseases;2024

5. The novel HS-mimetic, Tet-29, regulates immune cell trafficking across barriers of the CNS during inflammation;Journal of Neuroinflammation;2023-11-01